keyword
MENU ▼
Read by QxMD icon Read
search

ace and HCC

keyword
https://www.readbyqxmd.com/read/29998871/expression-analysis-of-apolipoproteins-ai-aiv-in-hepatocellular-carcinoma-a-protein-based-hepatocellular-carcinoma-associated-study
#1
Dipu Bharali, Basu Dev Banerjee, Mausumi Bharadwaj, Syed Akhtar Husain, Premashis Kar
Background & objectives: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality. The objective of this study was to find out the differential expression of apolipoproteins (ApoAI and ApoAIV) in HCC and cases of liver cirrhosis and chronic hepatitis (controls) without HCC and to compare ApoAI and ApoAIV expression with alpha-foetoprotein (AFP), the conventional marker in HCC. Methods: Fifty patients with HCC and 50 controls comprising patients with liver cirrhosis (n=25) and chronic hepatitis (n=25) without HCC were included in this study...
April 2018: Indian Journal of Medical Research
https://www.readbyqxmd.com/read/29983784/liver-protective-effects-of-renin-angiotensin-system-inhibition-have-no-survival-benefits-in-hepatocellular-carcinoma-induced-by-repetitive-administration-of-diethylnitrosamine-in-mice
#2
Sameh Saber, Amr Mahmoud, Noha Helal, Eman El-Ahwany, Rasha Abdelghany
BACKGROUND: Preclinical studies have demonstrated that renin-angiotensin system (RAS) signalling has strong tumour-promoting effects and RAS inhibition was associated with improvement in the overall survival in some cancer types including hepatocellular carcinoma (HCC). OBJECTIVE: We aimed to investigate the effect of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-II-receptor blockers (ARBs) on the survival of mice with diethylnitrosamine (DEN) induced HCC...
June 20, 2018: Open Access Macedonian Journal of Medical Sciences
https://www.readbyqxmd.com/read/29972254/an-ethyl-acetate-fraction-of-artemisia-capillaris-ace-63-induced-apoptosis-and-anti-angiogenesis-via-inhibition-of-pi3k-akt-signaling-in-hepatocellular-carcinoma
#3
Kyung Hee Jung, Marufa Rumman, Honghua Yan, Min Ji Cheon, Jin Gyu Choi, Xing Jin, Sunghouk Park, Myung Sook Oh, Soon-Sun Hong
In cancer treatment, herbal medicines may be a good choice because of the reduced risk of adverse side effects. Artemisia capillaris has been recognized as a promising candidate due to its hepatoprotective effects. Herein, we investigated whether A. capillaris-derived fraction (ACE-63) could inhibit the progression of hepatocellular carcinoma (HCC) and its underlying mechanism. In this study, ACE-63 effectively inhibited the growth and proliferation of HCC cells. ACE-63 induced apoptosis, as observed using Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, which was accompanied with increases in cleaved Poly (ADP-ribose) polymerase (PARP) and caspase-3 in HCC cells...
July 4, 2018: Phytotherapy Research: PTR
https://www.readbyqxmd.com/read/29859236/perindopril-fosinopril-and-losartan-inhibited-the-progression-of-diethylnitrosamine-induced-hepatocellular-carcinoma-in-mice-via-the-inactivation-of-nuclear-transcription-factor-kappa-b
#4
COMPARATIVE STUDY
Sameh Saber, Amr A A Mahmoud, Reham Goda, Noha S Helal, Eman El-Ahwany, Rasha H Abdelghany
Hepatocellular carcinoma (HCC) is a major global health problem. Therapeutic interventions of HCC are still limited because of its complicated molecular pathogenesis. Many reports showed that renin-angiotensin system (RAS) contributes to the development of different types of malignancies. Therefore, the present study aimed to examine the effect of RAS inhibition using perindopril (1 mg/kg), fosinopril (2 mg/kg), or losartan (10 mg/kg) on diethylnitrosamine-induced HCC compared to sorafenib (30 mg/kg)...
October 1, 2018: Toxicology Letters
https://www.readbyqxmd.com/read/29775725/anti-hepatitis-c-virus-activity-and-synergistic-effect-of-nymphaea-alba-extracts-and-bioactive-constituents-in-liver-infected-cells
#5
Sidra Rehman, Usman Ali Ashfaq, Bushra Ijaz, Sheikh Riazuddin
BACKGROUND: Without an effective vaccine, hepatitis C virus (HCV) remains a global threat, inflicting 170-300 million carriers worldwide at risk of cirrhosis and hepatocellular carcinoma (HCC). Though various direct acting antivirals have been redeemed the hepatitis C treatment, a few restraints persist including possible side effects, viral resistance emergence, excessive cost which restricts its availability to a common person. HYPOTHESIS: There is no preventive HCV vaccine available today so the discovery of potent antiviral natural flora and their bioactive constituents may help to develop preventive cures against HCV infection...
August 2018: Microbial Pathogenesis
https://www.readbyqxmd.com/read/29588589/hepatocellular-carcinoma-targeted-effect-of-configurations-and-groups-of-glycyrrhetinic-acid-by-evaluation-of-its-derivative-modified-liposomes
#6
Yuqi Sun, Chunmei Dai, Meilin Yin, Jinghua Lu, Haiyang Hu, Dawei Chen
Background: There are abundant glycyrrhetinic acid (GA) receptors on the cellular membrane of hepatocytes and hepatocellular carcinoma (HCC) cells. The receptor binding effect might be related to the structure of the guiding molecule. GA exists in two stereoisomers with C3-hydroxyl and C11-carbonyl active groups. Purpose: The objective of this study was to investigate the relationship between the HCC-targeted effect and the configurations and groups of GA. Methods and results: Different GA derivatives (18β-GA, 18α-GA, 3-acetyl-18β-GA [3-Ace-GA] and 11-deoxy-18β-GA [11-Deo-GA]) were used to investigate the targeting effect of GA's configurations and groups on HCC cells...
2018: International Journal of Nanomedicine
https://www.readbyqxmd.com/read/29163965/use-of-inhibitors-of-the-renin-angiotensin-system-is-associated-with-longer-survival-in-patients-with-hepatocellular-carcinoma
#7
Matthias Pinter, Arndt Weinmann, Marcus-Alexander Wörns, Florian Hucke, Simona Bota, Jens U Marquardt, Dan G Duda, Rakesh K Jain, Peter R Galle, Michael Trauner, Markus Peck-Radosavljevic, Wolfgang Sieghart
Background: Inhibition of the renin-angiotensin system (RAS) was associated with longer survival in patients with different solid malignancies. Objective: The objective of this study was to investigate the effect of RAS inhibitor (RASi) treatment (angiotensin-converting enzyme inhibitors or angiotensin-II-receptor blockers) on survival of patients with hepatocellular carcinoma (HCC). Methods: Patients diagnosed with HCC and Child-Pugh A between 1992 and 2013 who received sorafenib, experimental therapy, or best supportive care were eligible for the Vienna cohort...
November 2017: United European Gastroenterology Journal
https://www.readbyqxmd.com/read/28555333/the-value-of-11-c-acetate-pet-and-18-f-fdg-pet-in-hepatocellular-carcinoma-before-and-after-treatment-with-transarterial-chemoembolization-and-bevacizumab
#8
Shuren Li, Markus Peck-Radosavljevic, Philipp Ubl, Wolfgang Wadsak, Markus Mitterhauser, Eva Rainer, Matthias Pinter, Hao Wang, Christian Nanoff, Klaus Kaczirek, Alexander Haug, Marcus Hacker
PURPOSE: This prospective study was to investigate the value of [11 C]-acetate PET and [18 F]-FDG PET in the evaluation of hepatocellular carcinoma (HCC) before and after treatment with transarterial chemoembolization (TACE) and vascular endothelial growth factor (VEGF) antibody (bevacizumab). METHODS: Twenty-two patients (three women, 19 men; 62 ± 8 years) with HCC verified by histopathology were treated with TACE and bevacizumab (n = 11) or placebo (n = 11)...
September 2017: European Journal of Nuclear Medicine and Molecular Imaging
https://www.readbyqxmd.com/read/28086233/a-novel-benzimidazole-derivative-mbic-inhibits-tumor-growth-and-promotes-apoptosis-via-activation-of-ros-dependent-jnk-signaling-pathway-in-hepatocellular-carcinoma
#9
Xiaoyun Dai, Lingzhi Wang, Amudha Deivasigamni, Chung Yeng Looi, Chandrabose Karthikeyan, Piyush Trivedi, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Frank Arfuso, Arunasalam Dharmarajan, Boon Cher Goh, Kam Man Hui, Alan Prem Kumar, Mohd Rais Mustafa, Gautam Sethi
A prior screening programme carried out using MTT assay by our group identified a series of novel benzimidazole derivatives, among which Methyl 2-(5-fluoro-2-hydroxyphenyl)-1H- benzo[d]imidazole-5-carboxylate (MBIC) showed highest anticancer efficacy compared to that of chemotherapeutic agent, cisplatin. In the present study, we found that MBIC inhibited cell viability in different hepatocellular carcinoma (HCC) cell lines without exerting significant cytotoxic effects on normal liver cells. Annexin V-FITC/PI flow cytometry analysis and Western blotting results indicated that MBIC can induce apoptosis in HCC cells, which was found to be mediated through mitochondria associated proteins ultimately leading to the activation of caspase-3...
February 21, 2017: Oncotarget
https://www.readbyqxmd.com/read/26600713/metabolic-differentiation-and-classification-of-abnormal-savda-munziq-s-pharmacodynamic-role-on-rat-models-with-different-diseases-by-nuclear-magnetic-resonance-based-metabonomics
#10
Batur Mamtimin, Guo Xia, Mahmut Mijit, Mawlanjan Hizbulla, Nazuk Kurbantay, Li You, Halmurat Upur
BACKGROUND: Abnormal Savda Munziq (ASMq) is a traditional Uyghur herbal preparation used as a therapy for abnormal Savda-related diseases. In this study, we investigate ASMq's dynamic effects on abnormal Savda rat models under different disease conditions. MATERIALS AND METHODS: Abnormal Savda rat models with hepatocellular carcinoma (HCC), type 2 diabetes mellitus (T2DM), and asthma dosed of ASMq. Serum samples of each animal tested by nuclear magnetic resonance spectroscopy and analyzed by orthogonal projection to latent structure with discriminant analysis...
October 2015: Pharmacognosy Magazine
https://www.readbyqxmd.com/read/26189518/chemoprevention-against-hepatocellular-carcinoma
#11
Jun-Ichi Okano, Yuki Fujise, Ryo Abe, Ryu Imamoto, Yoshikazu Murawaki
Since the majority of hepatocellular carcinoma (HCC) arises from a background of chronic liver diseases caused by infection with hepatitis C virus (HCV) and hepatitis B virus (HBV), chemoprevention targeting patients at high risk of HCC is feasible. In this review article, we summarize current knowledge of chemoprevention against HCC mostly using phytochemicals which have less toxicity than pharmaceutical agents. We describe in vivo and in vitro evidence and proposed mechanisms of beneficial effects of several compounds on the liver, including acyclic retinoid (ACR), angiotensin-converting enzyme inhibitors (ACEIs), caffeine, capsaicin, cepharanthine (CEP), cinnamaldehyde, curcumin, diallyl sulfide (DAS), eicosapentaenoic acid (EPA), epigallocatechin-3-gallate (EGCG), genistein, lycopene, resveratrol, silymarin, sulforaphane (SFN), and xanthohumol (XN)...
August 2011: Clinical Journal of Gastroenterology
https://www.readbyqxmd.com/read/25701390/the-association-of-renin-angiotensin-system-genes-with-the-progression-of-hepatocellular-carcinoma
#12
Guanxiong Ye, Yong Qin, Xianghong Lu, Xiangdong Xu, Shengqian Xu, Chengjun Wu, Xinmei Wang, Shi Wang, Debiao Pan
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Angiogenesis is reported to play a pivotal role in the occurrence, development and metastasis of HCC. The renin-angiotensin system (RAS) is involved in the regulation of angiogenesis. Here, based on the analysis of HCC datasets from Gene Expression Omnibus (GEO) database and The Cancer Genome Atlas (TCGA), we found that there was a negative correlation between the mRNA levels of angiotensin converting enzyme 2 (ACE2) and CD34. To explore the association of RAS with the progression from fibrosis to cirrhosis to HCC, liver specimens and serum samples were collected from patients with hepatic fibrosis, cirrhosis and HCC...
March 27, 2015: Biochemical and Biophysical Research Communications
https://www.readbyqxmd.com/read/25354682/tumor-specific-suicide-gene-therapy-for-hepatocellular-carcinoma-by-transcriptionally-targeted-retroviral-replicating-vectors
#13
Y-H Lai, C-C Lin, S-H Chen, C-K Tai
Replicating virus vectors are attractive tools for anticancer gene therapy, but the potential for adverse events due to uncontrolled spread of the vectors has been a major concern. To design a tumor-specific retroviral replicating vector (RRV), we replaced the U3 region of the RRV ACE-GFP with a regulatory sequence consisting of the hepatitis B virus enhancer II (EII) and human α-fetoprotein (AFP) core promoter to produce ACE-GFP-EIIAFP, a hepatocellular carcinoma (HCC)-targeting RRV. Similar to ACE-GFP, ACE-GFP-EIIAFP exhibited robust green fluorescent protein (GFP) expression in HCC cells and, most importantly, it exhibited HCC-specific replication and did not replicate in non-HCC tumor cells or normal liver cells...
February 2015: Gene Therapy
https://www.readbyqxmd.com/read/25208933/relationship-between-polymorphism-of-angiotensin-converting-enzyme-gene-insertion-deletion-and-risk-of-hepatocellular-carcinoma-in-a-chinese-dai-population
#14
Yong Zha, Ping Gan, Qin Liu, Jing Tan
INTRODUCTION: The angiotensin-converting enzyme gene (ACE) is directly involved in the process of cancer cell proliferation, differentiation, apoptosis and angiogenesis. It also plays a vital role in inducing liver fibrosis and developing hepatocellular carcinoma (HCC). The aim of this study was to investigate the relationship between ACE insertion/deletion (I/D) polymorphism and the risk of HCC in a Chinese Dai population. MATERIALS AND METHODS: We conducted a study including 210 patients with HCC and 206 healthy controls in Yunnan Cancer Hospital between January 2012-January 2014...
September 2015: Journal of the Renin-angiotensin-aldosterone System: JRAAS
https://www.readbyqxmd.com/read/24696677/prophylactic-role-of-averrhoa-carambola-star-fruit-extract-against-chemically-induced-hepatocellular-carcinoma-in-swiss-albino-mice
#15
Ritu Singh, Jyoti Sharma, P K Goyal
Liver cancer remains one of the severe lethal malignancies worldwide and hepatocellular carcinoma (HCC) is the most common form. The current study was designed to evaluate the prophylactic role of the fruit of Averrhoa carambola (star fruit or Kamrak) on diethylnitrosamine- (DENA-) induced (15 mg/kg b.wt.; single i.p. injection) and CCl4-promoted (1.6 g/kg b.wt. in corn oil thrice a week for 24 weeks) liver cancer in Swiss albino mice. Administration of ACE was made orally at a dose of 25 mg/kg b...
2014: Advances in Pharmacological Sciences
https://www.readbyqxmd.com/read/24391821/effects-of-angiotensin-ii-type-2-receptor-overexpression-on-the-growth-of-hepatocellular-carcinoma-cells-in-vitro-and-in-vivo
#16
Hongyan Du, Zhibing Liang, Yanling Zhang, Feilong Jie, Jinlong Li, Yang Fei, Zhi Huang, Nana Pei, Suihai Wang, Andrew Li, Baihong Chen, Yi Zhang, Colin Sumners, Ming Li, Hongwei Li
Increasing evidence suggests that the renin-angiotensin system (RAS) plays an important role in tumorigenesis. The interaction between Angiotensin II (AngII) and angiotensin type 1 receptor (AT1R) may have a pivotal role in hepatocellular carcinoma (HCC) and therefore, AT1R blocker and angiotensin I-converting enzyme (ACE) inhibitors may have therapeutic potential in the treatment of hepatic cancer. Although the involvement of AT1R has been well explored, the role of the angiotensin II Type 2 receptor (AT2R) in HCC progression remains poorly understood...
2013: PloS One
https://www.readbyqxmd.com/read/24291100/targeting-different-angiogenic-pathways-with-combination-of-curcumin-leflunomide-and-perindopril-inhibits-diethylnitrosamine-induced-hepatocellular-carcinoma-in-mice
#17
Magda Nasr, Eman Selima, Omar Hamed, Amany Kazem
No effective chemopreventive agent has been approved against hepatocellular carcinoma (HCC) to date. Since HCC is one of the hypervascular solid tumors, blocking angiogenesis represents an intriguing approach to HCC chemoprevention. The aim of the current study was to examine the combined effect of the anti-angiogenic agents: leflunomide; a disease modifying antirheumatic drug, perindopril; an angiotensin converting enzyme inhibitor (ACEI) and curcumin; the active principle of turmeric, on diethylnitrosamine (DEN)-induced HCC in mice...
January 15, 2014: European Journal of Pharmacology
https://www.readbyqxmd.com/read/23570557/influence-of-angiotensin-i-converting-enzyme-gene-polymorphism-on-hepatocellular-carcinoma-risk-in-china
#18
Fang Yuan, Lu-Shun Zhang, Hong-Yu Li, Miao Liao, Meili Lv, Chongjie Zhang
Growing evidence suggests that the angiotensin-converting enzyme (ACE) and endothelial nitric oxide synthase (eNOS) genes are associated with risk in a wide range of cancers. The objective of this study was to examine whether two DNA polymorphisms at the ACE insertion/deletion (I/D) and the variable number of tandem repeats in NOS intron 4 (4a/4b) were linked to the risk of developing hepatocellular carcinoma (HCC) in a Chinese population. The polymorphisms at ACE I/D and eNOS 4a/4b were genotyped in 293 HCC patients and 384 healthy control subjects using polymerase chain reaction...
May 2013: DNA and Cell Biology
https://www.readbyqxmd.com/read/23442595/characterization-of-hepatic-tumors-using-11c-metomidate-through-positron-emission-tomography-comparison-with-11c-acetate
#19
Anne Roivainen, Alexandru Naum, Heikki Nuutinen, Rauli Leino, Heimo Nurmi, Kjell Någren, Riitta Parkkola, Johanna Virtanen, Markku Kallajoki, Harry Kujari, Jari Ovaska, Peter Roberts, Marko Seppänen
BACKGROUND: Using positron emission tomography (PET), we compared two tracers, [11C]metomidate ([11C]MTO) and [11C]acetate ([11C]ACE), for the characterization of hepatic tumors. METHODS: Thirty-three patients underwent PET with [11C]MTO and [11C]ACE and magnetic resonance imaging (MRI). Based on the histology of the tumor biopsy, 14 patients had hepatocellular carcinoma (HCC), 9 patients had focal nodular hyperplasia (FNH), and 10 patients had other types of hepatic tumors...
2013: EJNMMI Research
https://www.readbyqxmd.com/read/22870131/soluble-vegf-receptor-2-may-be-a-predictive-marker-of-anti-angiogenic-therapy-with-clinically-available-safe-agents
#20
Hitoshi Yoshiji, Ryuichi Noguchi, Yasuhide Ikenaka, Kosuke Kaji, Yusaku Shirai, Yosuke Aihara, Junichi Yamao, Masahisa Toyohara, Akira Mitoro, Masayoshi Sawai, Motoyuki Yoshida, Chie Morioka, Masao Fujimoto, Masahito Uemura, Hideto Kawaratani, Tatsuhiro Tsujimoto, Hiroshi Fukui
The identification of biomarkers of anti-angiogenic therapy that predict clinical benefit is of vital importance. We previously reported that a combination treatment with clinically available safe agents, specifically angiotensin-converting enzyme inhibitor (ACE-I) and vitamin K (VK), inhibited the cumulative recurrence of hepatocellular carcinoma (HCC) via suppression of the vascular endothelial growth factor (VEGF). The present study aimed to identify non-invasive biological markers that predict the clinically beneficial effect of this combination regimen...
January 2011: Oncology Letters
keyword
keyword
167396
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"